Nanalysis Scientific Corp.
NSCIF
$0.1858
$0.00040.22%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.66% | 57.44% | 64.79% | 51.54% | 43.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.66% | 57.44% | 64.79% | 51.54% | 43.15% |
| Cost of Revenue | 7.96% | 31.83% | 44.83% | 44.45% | 68.77% |
| Gross Profit | 99.62% | 215.40% | 193.81% | 82.59% | -14.85% |
| SG&A Expenses | -6.10% | -10.39% | -17.33% | -18.63% | -21.39% |
| Depreciation & Amortization | -6.87% | -1.78% | -7.81% | -8.90% | -9.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49% | 14.98% | 16.20% | 13.53% | 17.37% |
| Operating Income | 73.33% | 74.56% | 63.75% | 51.21% | 27.36% |
| Income Before Tax | 17.23% | 20.85% | 63.17% | 23.01% | -2.84% |
| Income Tax Expenses | -96.20% | -6.12% | 157.87% | 164.13% | 148.27% |
| Earnings from Continuing Operations | 20.10% | 20.88% | 54.26% | 9.90% | -16.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -100.00% | -100.00% | -80.56% |
| Net Income | 18.89% | 18.02% | 51.60% | 2.23% | -25.50% |
| EBIT | 73.33% | 74.56% | 63.75% | 51.21% | 27.36% |
| EBITDA | 71.88% | 84.19% | 68.23% | 59.35% | 36.45% |
| EPS Basic | 27.40% | 26.73% | 55.53% | 9.48% | -16.94% |
| Normalized Basic EPS | 60.08% | 57.55% | 51.42% | 34.40% | 11.50% |
| EPS Diluted | 22.92% | 22.73% | 51.51% | 11.29% | -14.54% |
| Normalized Diluted EPS | 60.08% | 57.55% | 51.42% | 34.40% | 11.50% |
| Average Basic Shares Outstanding | 11.62% | 11.57% | 10.65% | 9.68% | 7.49% |
| Average Diluted Shares Outstanding | 11.62% | 11.57% | 10.65% | 9.68% | 7.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |